Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Magnus Sjögren(Karolinska Institutet), A. Wallin(University of Gothenburg), Lars Rosengren(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Pia Davidsson(AstraZeneca (South Korea)), Lennart Minthon(Lund University)
Cited by 181
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
|The Lancet Neurology|2020|1.3k
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
|The Lancet Neurology|2017|630